New insights into the causes and treatments of Alzheimer’s are offering hope for those at risk and those who are battling the ...

Scientists have found a possible explanation for why cancer patients are less likely to develop Alzheimer's. The enemy of our ...

Conventional treatments of Alzheimer's disease, one of the most common forms of dementia, have been largely focused on ...

Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...

Researchers connecting pieces of the massive Alzheimer's puzzle are closer to slotting the next one in place, with yet ...

The FDA has set a Prescription Drug User Fee Act action date for 24 May 2026.

Alzheimer’s disease is a progressive neurodegenerative disease that affects an individual’s behavior, memory, and mental capabilities. Alzheimer’s allows for the build-up of proteins in the brain, ...

Alzheimer's disease has long been thought to be irreversible, but new research using a mouse model offers hope.

Panelists discuss how APPs facilitate efficient Alzheimer treatment timelines through proactive coordination. Panelists discuss how initiating Alzheimer therapy demands precise timing and ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

People often worry they will get Alzheimer’s disease if their parents did. But engaging in a healthy lifestyle can outweigh ...

Dana Territo, a champion of people with Alzheimer’s and a longtime Advocate columnist, died Sunday night at 67 after lengthy ...